ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Can Anastrozole Decrease IGF-1 and anabolic drive?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Gene Devine" data-source="post: 3299" data-attributes="member: 4"><p>Estrogen status can definitely effect IGF-1 serum levels!</p><p></p><p>This study suggests an AI can have a positive effect on IGF-1 serum levels. </p><p></p><p><strong>Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients.</strong><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Ferrari%20L%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Ferrari L</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Martinetti%20A%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Martinetti A</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Zilembo%20N%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Zilembo N</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Pozzi%20P%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Pozzi P</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Buzzoni%20R%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Buzzoni R</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=La%20Torre%20I%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">La Torre I</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Gattinoni%20L%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Gattinoni L</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Catena%20L%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Catena L</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Vitali%20M%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Vitali M</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Celio%20L%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Celio L</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Seregni%20E%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Seregni E</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Bombardieri%20E%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Bombardieri E</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Bajetta%20E%5BAuthor%5D&cauthor=true&cauthor_uid=11983488" target="_blank">Bajetta E</a>.</p><p>[h=3]Source[/b]Nuclear Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori of Milan, Via G. Venezian, 1, 20133 Milan, Italy.</p><p></p><p>[h=3]Abstract[/b]Insulin-like growth factors (IGFs) play a fundamental role in cancer development by acting in both an endocrinal and paracrinal manner, and hormone breast cancer treatments affect the IGF system by modifying circulating growth factor levels. We evaluated total IGF-1, IGF-2, IGF binding protein (IGFBP)-1 and IGFBP-3 in the blood of 34 postmenopausal advanced breast cancer patients (median age 63 years, range 41-85) treated with anastrozole, a non-steroidal structure aromatase inhibitor (NSS-AI). The plasma samples were obtained at baseline, and after 2, 4, 8 and 12 weeks of treatment. The IGFs were quantitated by means of sensitive radioimmunoassays (RIAs). <strong>IGF-1 significantly increased during anastrozole treatment</strong> (baseline versus 12 weeks, P=0.031), IGF-2 showed a trend towards an increase, and IGFBP-1 constantly but not significantly decreased; IGFBP-3 did not seem to be affected at all. The anastrozole-induced changes in IGFs and IGFBP-1 appeared to be different in the patients receiving a clinical benefit from those observed in non-responders. We have previously shown that letrozole (a different type of NSS-AI) modifies blood IGF-1 levels, and the results of this study of the biological effects of anastrozole on the components of the IGF system confirm our previous observations.</p></blockquote><p></p>
[QUOTE="Gene Devine, post: 3299, member: 4"] Estrogen status can definitely effect IGF-1 serum levels! This study suggests an AI can have a positive effect on IGF-1 serum levels. [b]Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients.[/b][URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Ferrari%20L%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Ferrari L[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Martinetti%20A%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Martinetti A[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Zilembo%20N%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Zilembo N[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Pozzi%20P%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Pozzi P[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Buzzoni%20R%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Buzzoni R[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=La%20Torre%20I%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]La Torre I[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Gattinoni%20L%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Gattinoni L[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Catena%20L%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Catena L[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Vitali%20M%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Vitali M[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Celio%20L%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Celio L[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Seregni%20E%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Seregni E[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Bombardieri%20E%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Bombardieri E[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed?term=Bajetta%20E%5BAuthor%5D&cauthor=true&cauthor_uid=11983488"]Bajetta E[/URL]. [h=3]Source[/b]Nuclear Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori of Milan, Via G. Venezian, 1, 20133 Milan, Italy. [h=3]Abstract[/b]Insulin-like growth factors (IGFs) play a fundamental role in cancer development by acting in both an endocrinal and paracrinal manner, and hormone breast cancer treatments affect the IGF system by modifying circulating growth factor levels. We evaluated total IGF-1, IGF-2, IGF binding protein (IGFBP)-1 and IGFBP-3 in the blood of 34 postmenopausal advanced breast cancer patients (median age 63 years, range 41-85) treated with anastrozole, a non-steroidal structure aromatase inhibitor (NSS-AI). The plasma samples were obtained at baseline, and after 2, 4, 8 and 12 weeks of treatment. The IGFs were quantitated by means of sensitive radioimmunoassays (RIAs). [B]IGF-1 significantly increased during anastrozole treatment[/B] (baseline versus 12 weeks, P=0.031), IGF-2 showed a trend towards an increase, and IGFBP-1 constantly but not significantly decreased; IGFBP-3 did not seem to be affected at all. The anastrozole-induced changes in IGFs and IGFBP-1 appeared to be different in the patients receiving a clinical benefit from those observed in non-responders. We have previously shown that letrozole (a different type of NSS-AI) modifies blood IGF-1 levels, and the results of this study of the biological effects of anastrozole on the components of the IGF system confirm our previous observations. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Can Anastrozole Decrease IGF-1 and anabolic drive?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top